ARTICLE | Company News
GTC Biotherapeutics, Leo Pharma deal
June 19, 2006 7:00 AM UTC
GTCB received a $1 million milestone payment from Leo under their 2005 deal to develop and market GTCB's ATryn human antithrombin in Europe, the Middle East and Canada (see BioCentury, Nov. 7, 2005)....